Filter
1419
Filtered Results: 1419
Text search:
World
Health
Organization,
Pan
American
Health
Organization
Featured
Recommendations
155
New Publications
270
Language
Document type
No document type
558
Studies & Reports
313
Guidelines
277
Manuals
99
Strategic & Response Plan
59
Fact sheets
36
Training Material
32
Situation Updates
17
Resource Platforms
11
Infographics
9
Brochures
5
Online Courses
3
Countries / Regions
Latin America and the Carribbean
159
Global
88
Brazil
69
Colombia
35
Venezuela
29
Haiti
25
Paraguay
24
Africa
23
Mozambique
20
India
17
Angola
17
Argentina
15
North America
12
Guinea-Bissau
10
Peru
10
Western and Central Europe
10
Syria
9
Kenya
9
Nigeria
8
Ecuador
8
Myanmar / Burma
8
Chile
8
Middle East and North Africa
8
Ethiopia
7
Philippines
7
Nepal
7
Asia
7
Russia
7
Liberia
6
Ukraine
6
Bolivia
6
Yemen
6
West and Central Africa
6
Ghana
5
Uganda
5
South Sudan
5
South Africa
5
Eastern Europe
5
Zambia
4
Tanzania
4
Cambodia
4
Indonesia
4
Bangladesh
4
Eswatini/ Swaziland
4
Mexico
4
East and Southern Africa
4
Burkina Faso
3
Sierra Leone
3
Congo, Democratic Republic of
3
Pakistan
3
Malawi
3
Honduras
3
Guatemala
3
Iran
3
Zimbabwe
2
China
2
Rwanda
2
Papua New Guinea
2
Sudan
2
El Salvador
2
South–East Asia Region
2
Western Pacific Region
2
Moldova
2
Uruguay
2
Jamaica
2
Spain
2
Guinea
1
Mali
1
Morocco
1
Saudi Arabia
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Thailand
1
Benin
1
Central African Republic
1
Dominican Republic
1
Namibia
1
Cuba
1
Botswana
1
Greece
1
Libya
1
Madagascar
1
Lesotho
1
Nicaragua
1
Eastern Europe and Central Asia
1
Fiji
1
Italy
1
Albania
1
Laos
1
Tajikistan
1
Estonia
1
Kyrgyzstan
1
Georgia
1
Vietnam
1
Japan
1
France
1
Tunisia
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
387
Clinical Guidelines
166
Public Health
107
Women & Child Health
78
Key Resources
76
Capacity Building
23
Pharmacy & Technologies
23
Annual Report MEDBOX
1
Toolboxes
COVID-19
252
Mental Health
130
HIV
91
Rapid Response
79
TB
75
NTDs
69
Planetary Health
65
Zika
61
Caregiver
42
NCDs
41
AMR
33
Disability
31
Global Health Education
30
Natural Hazards
23
Pharmacy
21
Conflict
20
Ebola
19
Cholera
16
Health Financing Toolbox
15
Refugee
13
Specific Hazards
6
Polio
5
Typhoon
2
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do...
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean,...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterrane...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterrane...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterrane...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South ... and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
This country profile presents a summary and analysis of Argentina's status with yellow fever. It is part of a series of profiles on this topic, each focusing on a different country in the Region of the Americas. Argentina's geographical location pre...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population),...
Advances in the treatment of pediatric cancer have made it possible to expand initiatives beyond cure and cover aspects such as early detection, continuity of treatment and reduction in toxicity. All this has paved the way for a more comprehensive vision of patient care, which means better chances o...
Los avances en el tratamiento del cáncer pediátrico han permitido ampliar las iniciativas más allá de la curación y abarcar aspectos como la detección precoz, la continuidad del tratamiento y la reducción de su toxicidad. Todo ello ha abierto paso a una visión más integral del cuidado de lo...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum ...-African polyvalent antivenoms: products that are intended for widespread utility throughout sub-Saharan Africa for treatment of envenoming irrespective of the species of snake causing a bite. Monovalent antivenoms for specific use cases: for products for a single species (or genus) of snake (e.g., boomslangs or carpet viper antivenoms).
Syndromic Pan-African polyvalent antivenoms for neurotoxic envenoming: products that are intended for treatment of envenoming by species whose venoms are neurotoxic. Syndromic Pan-African polyvalent antivenoms for non-neurotoxic envenoming: products for snakebite envenoming where the effects are largely haemorrhagic, necrotic or procoagulant.
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
Lessons learned in developing community mental health care in Latin American and Caribbean countries
This paper summarizes the findings for the Latin American and Caribbean countries of the WPA Task Force on Steps, Obstacles and Mistakes to Avoid in the Implementation of Community Mental Health Car...
The World health statistics report is the annual compilation of health and health-related indica...
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health...
Primary care - Putting people first: This chapter describes how primary care brings promotion and prevention, cure and care together in a safe, effective and socially productive way at the interface between the population and the health system.
Every day in 2020, approximately 800 women died from preventable causes related to pregnancy and childbirth - meaning that a woman dies around every two minutes.
Sustainable Development Goal (SDG) target 3.1 is to reduce maternal mortality to less than 70 maternal deaths per 100 000 live births by ...
There is growing understanding and high-level endorsement of the importance of strong collaborative multisectoral approaches to address a broad range of social, economic and governance issues for the prevention and control of noncommunicable disease (NCDs) and mental ... conditions. In 2019, World Health Organization (WHO) Member States requested the WHO Director-General to provide an analysis across countries of successful approaches for the prevention and control of NCDs that used multisectoral action. This WebAnnex to the Global mapping report on multisectoral actions to strengthen the prevention and control of noncommunicable diseases and mental health conditions details experiences from around the world.
